FIELD: chemistry.
SUBSTANCE: invention relates to use of 11H-indeno[1,2-b]quinoxaline-11-one sodium salt of oxime.
EFFECT: agent has antiaggregant activity.
1 cl, 3 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
HEMORHEOLOGICAL AND ANTI-THROMBOSIS AGENT | 2003 |
|
RU2242221C1 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
HEMORHEOLOGICAL AND ANTITHROMBOTIC AGENT | 2003 |
|
RU2239423C1 |
DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
USING SECOISOLARICIRESINOL AS HAEMORHEOLOGICAL, ANTI-PLATELET AND ENDOTHELIUM-PROTECTIVE AGENT | 2013 |
|
RU2532356C1 |
PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
AGENT WITH ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2015 |
|
RU2601407C1 |
Authors
Dates
2019-08-05—Published
2019-03-21—Filed